Open AccessEvaluation of the association of SNP in carboxylesterase enzyme (CES1) with pharmacokinetic and adverse effects of capecitabine in breast and colorectal cancer patients
Author(s) -
Merve Kurtan Yuksel,
Dilek Öztürk,
Ezgi Öztaş,
Gül Özhan,
Aylin Altanlar Turker,
Taner Korkmaz,
Alper Okyar,
Zeliha Pala Kara
Publication year - 2019
Publication title -
istanbul university journal of pharmacy/istanbul journal of pharmacy :
Language(s) - English
Resource type - Journals
eISSN - 2587-2087
pISSN - 2548-0731
DOI - 10.26650/istanbuljpharm.2019.19018
Subject(s) - capecitabine , pharmacokinetics , pharmacology , cyp2d6 , cmax , adverse effect , medicine , pharmacogenetics , oncology , genotype , chemistry , colorectal cancer , cancer , biochemistry , cytochrome p450 , metabolism , gene